Pastolero, Kenalyn B.
HRN: 24-88-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2024
CEFTRIAXONE 1G (VIAL)
04/18/2024
04/25/2024
IV
2g
Q24H
Reactive Cholecystitis; Hepatic Congestion
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes